Understand the source comparison
Best LIPO-C Dosage Energy 2026: Protocol Comparison
Baseline methylation support (maintenance calories, normal liver enzymes) 0.5mL weekly Morning, fasted state, 30+ min before first meal Compatible with all non-hepatotoxic compounds Sufficient for subjects not in caloric deficit or using metabolic stressors Mo
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Baseline methylation support (maintenance calories, normal liver enzymes)
- 0.5mL weekly
- Morning, fasted state, 30+ min before first meal
- Compatible with all non-hepatotoxic compounds
- Sufficient for subjects not in caloric deficit or using metabolic stressors
- Moderate caloric deficit support (10–20% below maintenance)
- 1mL weekly
- Morning, fasted state, avoid same-day thermogenic use
- Reduce dose to 0.75mL if using GLP-1 agonists
- Addresses increased methyl donor demand during moderate restriction
- Sustained deficit or hepatic steatosis (20%+ below maintenance, elevated liver enzymes)
- 1.5–2mL weekly
- Morning, fasted state, monitor liver enzymes at 4 weeks
- Incompatible with concurrent hepatotoxic compounds or alcohol
- Maximum dose. Requires liver function monitoring
- Energy support during concurrent peptide protocols (MK 677, Tesofensine)
- 1–1.5mL weekly
- Administer 48 hours post-peptide injection
- Space from compounds that elevate hepatic metabolic load
- Prevents methyl donor depletion during increased liver activity
- Pre-competition or final-phase fat loss (extreme deficit, 25%+ below maintenance)
- 2mL weekly for max 6 weeks
- Morning, fasted, discontinue if ALT/AST rise >20% from baseline
- Contraindicated with concurrent diuretics or nephrotoxic agents
- Short-term protocol only. Not sustainable beyond 6 weeks